Cargando…

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children

Respiratory drugs are widely used in children to treat labeled and non-labeled indications but only some data are available quantifying comprehensively off-label usage. Thus, we aim to analyse drug utilisation and off-label prescribing of respiratory drugs focusing on age- and indication-related off...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmiedl, Sven, Fischer, Rainald, Ibáñez, Luisa, Fortuny, Joan, Klungel, Olaf H., Reynolds, Robert, Gerlach, Roman, Tauscher, Martin, Thürmann, Petra, Hasford, Joerg, Rottenkolber, Marietta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152124/ https://www.ncbi.nlm.nih.gov/pubmed/25180704 http://dx.doi.org/10.1371/journal.pone.0105110

Ejemplares similares

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Time Trends of Period Prevalence Rates of Patients with Inhaled Long-Acting Beta-2-Agonists-Containing Prescriptions: A European Comparative Database Study
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

A compilation of research working groups on drug utilisation across Europe
por: Sabaté, Mònica, et al.
Publicado: (2014)

Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007–2010
por: Ferrer, Pili, et al.
Publicado: (2015)

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues
por: Hasford, J., et al.
Publicado: (2021)

Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014)

Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Souverein, Patrick C., et al.
Publicado: (2020)

Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring
por: Zapke, Sonja E., et al.
Publicado: (2021)

Prevalence of antibiotic use: a comparison across various European health care data sources
por: Brauer, Ruth, et al.
Publicado: (2015)

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies
por: van den Ham, Hendrika A., et al.
Publicado: (2021)

Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability
por: Schmiedl, Sven, et al.
Publicado: (2019)

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study
por: Ibáñez, Luisa, et al.
Publicado: (2019)

Patterns and predictors of off-label prescription of psychiatric drugs
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
por: Lai, L Leanne, et al.
Publicado: (2011)

Off-label prescriptions in intensive care unit: the Chinese experience
por: Liu, Lin, et al.
Publicado: (2018)

Clinical utility of overviews on adverse events of pharmacological interventions
por: Sachse, Thilo, et al.
Publicado: (2023)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care
por: Mann, Nina-Kristin, et al.
Publicado: (2022)

Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults
por: Dedroogh, Simon, et al.
Publicado: (2023)

12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
por: Ebrahimi, Seyyed Reza Sadat
Publicado: (2017)

Drug utilisation and off-label use of medications in anaesthesia in surgical wards of a teaching hospital
por: Patil, Amol E, et al.
Publicado: (2015)

An Unappreciated Cause for the Falling off of Prescriptions
Publicado: (1916)

The Unlicensed and Off-Label Prescription of Medications in General Paediatric Ward: An Observational Study
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2019)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Profiling off-label prescriptions in cancer treatment using social health networks
por: Nikfarjam, Azadeh, et al.
Publicado: (2019)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023)

The role of qualification and quality management in the prescription of antipsychotics and potentially inappropriate medication (PIM) in nursing home residents in Germany: results of the HIOPP-3-iTBX study
por: Stolz, Regina, et al.
Publicado: (2023)

The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review
por: Howe, Katrina, et al.
Publicado: (2021)

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)
por: Sabaté, M., et al.
Publicado: (2021)

Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data
por: Stausberg, Jürgen, et al.
Publicado: (2011)

Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
por: Bramlage, Peter, et al.
Publicado: (2009)

Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
por: Kim, Daria, et al.
Publicado: (2020)

Four reasons why too many informed consents to clinical research are invalid: a critical analysis of current practices
por: Wisgalla, Anne, et al.
Publicado: (2022)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Trade-offs between Sustainable Development Goals in carbon capture and utilisation
por: Ioannou, Iasonas, et al.
Publicado: (2022)

Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
por: Wilkes, Michael, et al.
Publicado: (2008)

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
por: Kimland, E, et al.
Publicado: (2012)

Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany
por: Lücke, Caroline, et al.
Publicado: (2018)

Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit
por: Vieira, Verônica Cheles, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_slj2rh9p8imait66loasl5e40k